AtriCure (ATRC) Tops Q2 EPS by 22c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $58.10 -1.73%
EPS Growth %: -300.0%
Financial Fact:
Basic and diluted net loss per share: -0.21
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: -300.0%
Financial Fact:
Basic and diluted net loss per share: -0.21
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q2 EPS of ($0.01), $0.22 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $51.8 million versus the consensus estimate of $49.9 million.
GUIDANCE:
AtriCure sees FY2018 revenue of $193-197 million, versus the consensus of $195 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Investing.com’s stocks of the week
- UBS cuts KOSPI target by nearly 10% to reflect higher rates
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
